Dynacure
  • Company
    • Company
    • Management
    • Supervisory Board
  • Disease Area
  • Patients
  • R&D
    • DYN 101
    • Antisense oligonucleotide
    • Publications
  • Investors
  • News
  • Contact
Select Page

Morice sends us a message

Morice is his parents’ pride and joy. This two-year-old from the outskirts of Hanover, Germany, presents the classic X-linked form of CNM – a diagnosis that was reached only after a long and difficult journey. But instead of letting this devastating news get the better of them, Morice’s parents made a vow to never stop fighting for their son.

Read Morice's Story

message

understood

ABOUT DYNACURE

Dynacure is a biotechnology company developing new treatments for patients affected by serious orphan disorders. In its first drug discovery program, Dynacure is focusing on Centronuclear Myopathies (CNM), a debilitating rare disease affecting children and young adults.

DISCOVER MORE
Copyright © 2018 - Dynacure